Zhende Medical Co., Ltd.
603301
Rank in Stocks
#4849
Zhende Medical Co., Ltd. engages in the research and development, production,... Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; Surgical drape; standard surgical pack and custom procedure pack; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; and warming blanket system. In addition, the company offers isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.
Share Price
$11.60
Market Cap
$3.06B
Change (1 day)
2.99%
Change (1 year)
14.73%
Country
CN
Trade Zhende Medical Co., Ltd. (603301)
Category
Healthcare
P/E ratio for Zhende Medical Co., Ltd. (603301)
P/E ratio as of October 2026 TTM: 73.02
According to Zhende Medical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 73.02. At the end of 2023 the company had a P/E ratio of 33.27.
P/E ratio history for Zhende Medical Co., Ltd. from 2014 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 73.02 | 381.34% |
| 2024 | 15.17 | -54.42% |
| 2023 | 33.27 | 150.49% |
| 2022 | 13.28 | -31.74% |
| 2021 | 19.46 | 288.98% |
| 2020 | 5.00 | -74.23% |
| 2019 | 19.41 | -13.55% |
| 2018 | 22.46 | 27.47% |
| 2017 | 17.62 | -31.48% |
| 2016 | 25.71 | -4.57% |
| 2015 | 26.94 | -72.46% |
| 2014 | 97.81 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | -34.97% |
US
|
|
| 27.43 | -62.44% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -22.08% |
US
|
|
| - | - |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.